Full View

Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function

Z Szabó, L Vainio, R Lin, J Swan, JJ Hulmi… - FASEB Journal, 2020 - jyx.jyu.fi
Signaling through activin receptors regulates skeletal muscle mass and activin receptor 2B
(ACVR2B) ligands are also suggested to participate in myocardial infarction (MI) pathology …
被引用次数：8 相关文章

Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function

Z Szabó, L Vainio, R Lin, J Swan… - … publication of the …, 2020 - pubmed.ncbi.nlm.nih.gov
Signaling through activin receptors regulates skeletal muscle mass and activin receptor 2B
(ACVR2B) ligands are also suggested to participate in myocardial infarction (MI) pathology …

Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function

Z Szabó, L Vainio, R Lin, J Swan, JJ Hulmi… - 2023 - oulurepo.oulu.fi
Signaling through activin receptors regulates skeletal muscle mass and activin receptor 2B
(ACVR2B) ligands are also suggested to participate in myocardial infarction (MI) pathology …

Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function

Z Szabó, L Vainio, R Lin, J Swan, JJ Hulmi… - The FASEB …, 2020 - Wiley Online Library
Signaling through activin receptors regulates skeletal muscle mass and activin receptor 2B
(ACVR2B) ligands are also suggested to participate in myocardial infarction (MI) pathology …

Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function.

Z Szabó, L Vainio, R Lin, J Swan, JJ Hulmi… - … : Official Publication of …, 2020 - europepmc.org
Signaling through activin receptors regulates skeletal muscle mass and activin receptor 2B
(ACVR2B) ligands are also suggested to participate in myocardial infarction (MI) pathology …

[引用][C] Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function

Z Szabo, L Vainio, R Lin, J Swan, JJ Hulmi… - FASEB …, 2020 - researchportal.helsinki.fi
Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure
without compromising cardiac function — University of Helsinki Skip to main navigation Skip to …